Energetics of Cardiac Blood Flow in Hypertrophic Cardiomyopathy through Individualized Computational Modeling

Owen Baenen1,2, Angie Carolina Carreño-Martínez3, Theodore P Abraham3

  • 1Department of Mechanical Engineering, Rice University, Houston, TX 77005, USA.

Insights

Personalized computational fluid dynamics models reveal abnormal blood flow patterns in hypertrophic cardiomyopathy (HCM) patients. These findings in hypertrophic cardiomyopathy hearts suggest altered hemodynamics may worsen disease progression.

Area of Science:

  • Cardiovascular Physiology
  • Medical Imaging
  • Computational Fluid Dynamics

Background:

  • Hypertrophic cardiomyopathy (HCM) involves left ventricular (LV) wall thickening, potentially leading to cardiac dysfunction.
  • Altered blood flow patterns in HCM may exacerbate disease progression, but this is not well understood.
  • Patient-specific factors influencing these flow patterns remain largely unknown.

Purpose of the Study:

  • To develop personalized computational fluid dynamics (CFD) models of the left ventricle (LV) using cardiac magnetic resonance (cMR) images.
  • To investigate how cardiac hypertrophy and inter-patient variability affect intra-LV blood flow patterns.
  • To quantify flow patterns and energetics in normal and HCM patient-specific models.

Main Methods:

  • Generation of patient-specific CFD models of the LV from cMR imaging data.
  • Simulation of blood flow within the LV models to determine velocity fields.
  • Quantification of flow patterns, energy transfer timing, and kinetic energy distribution.

Main Results:

  • HCM hearts displayed anomalous intra-LV blood flow patterns compared to normal hearts.
  • A temporal mismatch in energy transfer from the LV wall to blood flow was observed in HCM.
  • Kinetic energy flow patterns were altered in the hypertrophic cardiomyopathy models.

Conclusions:

  • Personalized CFD modeling offers a promising approach for analyzing hemodynamics in HCM.
  • Aberrant flow patterns and energy transfer dynamics in HCM may contribute to disease progression.
  • This methodology could enhance clinical understanding and management of hypertrophic cardiomyopathy.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
678
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
14
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K